IMPROVED GLYCEMIC CONTROL FOR PREDIABETES AND/OR DIABETES TYPE II USING DOCOSAHEXAENOIC ACID
摘要
This invention is directed to methods of treating patients with metabolic syndrome, prediabetes and/or Type 11 diabetes mellitus by administering docosahexaenoic acid (DHA) alone or in combination with diabetes-related medications.
申请公布号
WO2004028469(A2)
申请公布日期
2004.04.08
申请号
WO2003US30483
申请日期
2003.09.29
申请人
MARTEK BIOSCIENCES CORPORATION;ARTERBURN, LINDA;BENISEK, DIANE;HOFFMAN, JAMES;OKEN, HARRY, A.;VAN ELSWYK, MARY
发明人
ARTERBURN, LINDA;BENISEK, DIANE;HOFFMAN, JAMES;OKEN, HARRY, A.;VAN ELSWYK, MARY
